Cargando…
Heart Failure with Preserved Ejection Fraction and Pulmonary Hypertension: Focus on Phosphodiesterase Inhibitors
Pulmonary hypertension (PH) is common in patients with heart failure with preserved ejection fraction (HFpEF). A chronic increase in mean left atrial pressure leads to passive remodeling in pulmonary veins and capillaries and modest PH (isolated postcapillary PH, Ipc-PH) and is not associated with s...
Autores principales: | Ovchinnikov, Artem, Potekhina, Alexandra, Belyavskiy, Evgeny, Ageev, Fail |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414416/ https://www.ncbi.nlm.nih.gov/pubmed/36015172 http://dx.doi.org/10.3390/ph15081024 |
Ejemplares similares
-
Phosphodiesterase 5 inhibitor sildenafil in patients with heart failure with preserved ejection fraction and combined pre- and postcapillary pulmonary hypertension: a randomized open-label pilot study
por: Belyavskiy, Evgeny, et al.
Publicado: (2020) -
Blood Immune Cell Alterations in Patients with Hypertensive Left Ventricular Hypertrophy and Heart Failure with Preserved Ejection Fraction
por: Ovchinnikov, Artem, et al.
Publicado: (2023) -
Asymptomatic Left Ventricular Hypertrophy Is a Potent Risk Factor for the Development of HFpEF but Not HFrEF: Results of a Retrospective Cohort Study
por: Ovchinnikov, Artem, et al.
Publicado: (2022) -
The Molecular and Cellular Mechanisms Associated with a Microvascular Inflammation in the Pathogenesis of Heart Failure with Preserved Ejection Fraction
por: Ovchinnikov, A. G., et al.
Publicado: (2020) -
Diagnosis and Management of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF): Current Perspectives and Recommendations
por: Dzhioeva, Olga, et al.
Publicado: (2020)